An observational study in Pancreatic Cancer, sponsored by Dartmouth-Hitchcock Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-10-14.
Sponsored by Dartmouth-Hitchcock Medical Center · Observational
The primary outcome measure for this study is plasma ghrelin level.
The primary outcome measure for this study is plasma ghrelin level, and the two primary comparison are:
3,310 studies on the registry are indexed under Pancreatic Neoplasms; 910 are open to participants now.
This study's enrollment of 72 is below the median of 200 across 636 observational studies indexed under Pancreatic Neoplasms.
Browse Pancreatic Neoplasms studies →Dartmouth-Hitchcock Medical Center is the lead sponsor of 486 studies on the registry; 69 are open to participants now.
Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Pancreatic cancer patients who have not received treatment. Healthy age-matched controls.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pancreatic cancer patients
Procedure: Blood draw
Healthy controls
Procedure: Blood draw
One blood draw prior to first treatment
To evaluate plasma ghrelin levels in patients with pancreatic cancer and compare with age matched controls
Time frame: prior to treatment
To investigate the role of ghrelin in pathophysiology of cancer cachexia
Time frame: prior to treatment
To generate hypotheses for future studies and treatment based on the findings
Time frame: prior to treatment
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dartmouth-Hitchcock Medical Center →